ALK-negative anaplastic large cell lymphoma with CNS involvement needs more than just brentuximab vedotin

Ann Hematol. 2016 Oct;95(10):1725-6. doi: 10.1007/s00277-016-2746-3. Epub 2016 Jul 27.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Blood-Brain Barrier
  • Brain / diagnostic imaging
  • Brain / pathology*
  • Brentuximab Vedotin
  • Female
  • Humans
  • Immunoconjugates / pharmacokinetics
  • Immunoconjugates / therapeutic use*
  • Lymphoma, Large-Cell, Anaplastic / diagnostic imaging
  • Lymphoma, Large-Cell, Anaplastic / drug therapy*
  • Lymphoma, Large-Cell, Anaplastic / pathology
  • Magnetic Resonance Imaging
  • Middle Aged
  • Positron Emission Tomography Computed Tomography
  • Recurrence
  • Remission Induction
  • Salvage Therapy*

Substances

  • Immunoconjugates
  • Brentuximab Vedotin